Mar
2017
Cerba HealthCare Press Release
Paris, France, March 21, 2017. Cerba Healthcare S.A.S. and its affiliates (the “Cerba Group”) announced today that NewCo Sab MidCo S.A.S...
Cerba HealthCare Press Release
Paris, France, March 21, 2017. Cerba Healthcare S.A.S. and its affiliates (the “Cerba Group”) announced today that NewCo Sab MidCo S.A.S...
Cerberus Nightingale 1
Notice of redemption
Finalization of shareholder change
Partners Group and PSP Investments have finalized the acquisition of Cerba HealthCare, a leading European operator of clinical pathology laboratories, from PAI Partners.
The acquisition of Fleming Research strengthens the positions of Cerba HealthCare in Italia
Cerba HealthCare announces the consolidation of its Italian business, Cerba HealthCare Italia, through the acquisition of Fleming Research — a firm with a network of diagnostic centres based in northern Italy (Lombardy and Piedmont).
Sale of Bio 7 to Cerba HealthCare
Exclusive agreement signed
Cerba HealthCare intends to offer €60.0 million in aggregate principal amount of its senior notes due 2025
Cerba HealthCare intends to offer €60.0 million in aggregate principal amount of its senior notes due 2025
€60.0 million senior notes due 2025 pricing
€60.0 million senior notes due 2025 pricing
Cerba announced today that the acquisition of Bio IDF Santé ("BIO 7") has been completed
Cerba announced today that the acquisition of Bio IDF Santé ("BIO 7") has been completed
Acquisition of ACCOLAB
Acquisition of ACCOLAB
Cerba HealthCare is establishing itself in Africa
Cerba HealthCare, a leading player in the field of clinical pathology in Europe, is establishing itself in Africa to develop Cerba Lancet Africa, a network of labs in partnership with Lancet Laboratories, South Africa’s leader in clinical pathology.